It has now been close to 15 years since the derivation of the first human embryonic stem cell (hESC) line.1 However, the legal, legislative, and political strife over the federal funding of hESC research continues unabated. The stakes are considerable because early translational efforts have entered the clinical trial arena.2 In this Viewpoint we trace the resolution of the latest legal challenge to the federal funding of hESC research and reflect on the future course of this important debate.
Cohen IG, Feigenbaum J, Adashi EY. Sherley v Sebelius and the Future of Stem Cell Research. JAMA. 2012;308(20):2087–2088. doi:10.1001/jama.2012.36633
Customize your JAMA Network experience by selecting one or more topics from the list below.